Pricing
  1. US-listed companies
  2. Ascendis Pharma A
  3. Financials
  4. Total assets

Ascendis Pharma A (ASND)

Market cap
P/E ratio
SummaryFinancials
Period EndTotal assets (Million EUR)YoY (%)
Dec 31, 20241,179+42.87%
Dec 31, 2023826-24.24%
Dec 31, 20221,090+0.44%
Dec 31, 20211,085+10.73%
Dec 31, 2020980+44.78%
Dec 31, 2019677+112.16%
Dec 31, 2018319+51.18%
Dec 31, 2017211

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat